source
- FDA unveils transparency roadmap with plans for public NDA/BLA disclosures and inspection report publishingThe FDA published a transparency roadmap that outlines its FY 2026 achievements and sets out priorities for FY 2027. One key priority is a proposal to require public disclosure of new drug applica…
- Congressional Bill Aims to End Arbitration in No Surprises Act, Shifting Payments to Median In-Network RatesRep. Frank Pallone introduced the Lower Premiums, Faster Payments Act, which would eliminate the arbitration system used under the No Surprises Act and replace it with a payment model based on medi…